首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   367篇
  免费   13篇
化学   182篇
力学   23篇
数学   36篇
物理学   139篇
  2022年   4篇
  2021年   3篇
  2020年   5篇
  2019年   6篇
  2018年   3篇
  2016年   8篇
  2015年   8篇
  2014年   12篇
  2013年   17篇
  2012年   16篇
  2011年   14篇
  2010年   9篇
  2009年   8篇
  2008年   10篇
  2007年   9篇
  2006年   20篇
  2005年   11篇
  2004年   12篇
  2003年   7篇
  2002年   20篇
  2001年   9篇
  2000年   9篇
  1999年   12篇
  1998年   6篇
  1997年   7篇
  1996年   3篇
  1995年   9篇
  1994年   11篇
  1993年   5篇
  1992年   6篇
  1989年   3篇
  1988年   5篇
  1985年   6篇
  1984年   4篇
  1983年   7篇
  1982年   8篇
  1981年   8篇
  1980年   2篇
  1978年   4篇
  1977年   7篇
  1976年   4篇
  1975年   2篇
  1974年   4篇
  1973年   6篇
  1971年   3篇
  1933年   5篇
  1930年   2篇
  1929年   2篇
  1886年   2篇
  1883年   2篇
排序方式: 共有380条查询结果,搜索用时 15 毫秒
11.
12.
Summary The complex [RuII(hedta)(4NH2pym)], hedta3− = N-hydroxyethylethylenediaminetriacetate, 4NH2pym = 4-aminopyrimidine, exists at pH 7 as five different coordination isomers, which are most readily distinguished by their electrochemical waves in comparison with the 2-aminopyridine (2NH2py) complex. The 2NH2py complex exhibits N(1) (pyridine bound), exo-NH2 (amine bound) and N(1), NH2-chelated species. The 4NH2pym complex forms N(1), exo-amine and N(3), NH2-chelated isomers analogues to the 2NH2py species, but also engages in η2 (olefin bound) coordination of the dearomatized 4NH2pym ring in C(5)–C(6), and another η2 type of complex involving electron density between N(1) and N(3) of the ring (η3 form). N(1), η2 and η3 isomers have also been detected for unsubstituted pyrimidine (pym), 4-methylprimidine (4CH3pym) and 2-aminopyrimidine (2NH2pym). Electrochemical waves (V versus NHE) for the five isomers are assigned as follows: (RuII/III) exo-NH2 (0.06 V), N(1) (0.29 V), η2 (0.49 V); (RuII/III) η3 (0.76 V); N(3), NH2-chelated (1.09 V).  相似文献   
13.
Summary The following [(NH3)5RhLH]Cl3 salts were preparedvia the [(NH3)5Rh(O3SCF3)](O3SCF3)2 synthetic route; LH=1-methylimidazole (1CH3imH), 2-methylimidazole (2CH3imH), 4-methylimidazole (4CH3imH), 5-methylimidazole(5CH3imH), and pyrazole (pyzH). pKa's at 25.0°C were determined for [(NH3)5RhLH]3+ complexes as follows: 2CH3imH, 10.4±0.1; 5CH3imH/4CH3imH isomer mixture, 10.3±0.1; pyzH, 6.54±0.05. The influence on the pKa's of imidazoles is dominated by withdrawal of the rhodium(III) centre and may be compensated by the presence of ring methylation by only 0.5log units for cobalt(III) and rhodium(III) derivatives, compared to 1.3 units for the -withdrawing ruthenium(III) centre. In the case of the -acceptor pyrazole ring, [(NH3)5Rh]3+ is observed to serve as a slight -donor and raises the pKa above the cobalt(III) analogue. The1H n.m.r. spectra of [(NH3)5RhLH]3+ complexes of the substituted imidazoles and pyrazole exhibit a deshielding order. C–2H>C–5H>C–4H for imidazoles and C–3H>C–5H>C–4H for pyrazole, as do their cobalt(III) analogues. The magnitude of values (=free L-complex) are virtually the same as in the cobalt(III) systems which shows that TIP influences are unimportant compared to ring rehybridization in estabilishing chemical shifts for both the cobalt(III) and rhodium(III) complexes. The imidazolato and pyrazolato complexes exhibit resonances upfield of the respective substituted imidazole or pyrazole complex in keeping with more negative charge on the rings; the influence is largest at C–2H of imidazolates and C–3H of pyrazolate.  相似文献   
14.
A simple and high-yielding method for the preparation of cyclopropane amino acids is described. The novel method involves the one-pot cyclopropanation of readily available dehydroamino acids using aryl and unsaturated diazo compounds generated in situ from the corresponding tosylhydrazone salts. It was found that thermal 1,3-dipolar cycloaddition followed by nitrogen extrusion gave the cyclopropane amino acid derivatives with good E selectivity, while reactions in the presence of meso-tetraphenylporphyrin iron chloride gave predominantly the corresponding Z isomers. The synthetic utility of this process was demonstrated in the synthesis of (+/-)-(Z)-2,3-methanophenylalanine [(+/-)-(Z)-1], the anti-Parkinson (+/-)-(E)-2,3-methano-m-tyrosine [(+/-)-(E)-2], and the natural product (+/-)-coronamic acid [(+/-)-3].  相似文献   
15.
16.
17.
18.
The facile production of ArCF2X and ArCX3 from ArCF3 using catalytic iron(III)halides is reported, which constitutes the first iron-catalyzed halogen exchange for non-aromatic C−F bonds. Theoretical calculations suggest direct activation of C−F bonds by iron coordination. ArCX3 and ArCF2X products of the reaction are synthetically valuable due to their diversification potential. In particular, chloro- and bromodifluoromethyl arenes (ArCF2Cl, ArCF2Br respectively) provide access to a myriad of difluoromethyl arene derivatives (ArCF2R). To optimize for mono-halogen exchange, a statistical method called Design of Experiments was used. Optimized parameters were successfully applied to electron rich and electron deficient aromatic substrates, and to the late stage diversification of flufenoxuron, a commercial insecticide. These methods are highly practical, being run at convenient temperatures and using inexpensive common reagents.  相似文献   
19.
Ventral and rostral regions of the brain are of emerging importance for the MRI characterization of early dementia, traumatic brain injury and epilepsy. Unfortunately, standard single-shot echo planar diffusion-weighted imaging of these regions at high fields is contaminated by severe imaging artifacts in the vicinity of air–tissue interfaces. To mitigate these artifacts and improve visualization of the temporal and frontal lobes at 7 T, we applied a reduced field-of-view strategy, enabled by outer volume suppression (OVS) with novel quadratic phase radiofrequency (RF) pulses, combined with partial Fourier and parallel imaging methods. The new acquisition greatly reduced the level of artifacts in six human subjects (including four patients with early symptoms of dementia).  相似文献   
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号